secwatch.observer — SEC 8-K summary
======================================

Issuer:     FILANA THERAPEUTICS, INC. (FLNA)
CIK:        0001069530
Form:       8-K
Filed at:   2024-05-22T23:59:59+00:00
Accession:  0001437749-24-018029
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Cassava Sciences awards $850k in discretionary bonuses to execs; CFO gets change-in-control severance
--------------------------------------------------------------------------------

- CEO Remi Barbier receives $500k discretionary cash bonus.
- CFO Eric Schoen receives $250k bonus; employment amended to include 12-month severance after change in control.
- General Counsel R. Christopher Cook and CMO James Kupiec each receive $50k bonus.
- Change in control defined as acquisition of 51% or more of outstanding shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1069530/000143774924018029/0001437749-24-018029-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1069530/000143774924018029/sava20240521_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-018029

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer